Sign In
Buy HRTX
$0.496
-0.0012 (-0.241%)
At Close: Jul 31, 2026
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
09:35pm, Thursday, 23'rd Mar 2023 Zacks Investment Research
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics, Inc. (HRTX) Q4 2022 Earnings Call Transcript
09:08pm, Thursday, 23'rd Mar 2023
Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants David Szekeres – Executive Vice President, Chief Operating Officer Barry Quart
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
07:03pm, Thursday, 23'rd Mar 2023
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharmaceutical (CPRX) Q4 Earnings and Revenues Surpass Estimates
09:25pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
Catalyst (CPRX) delivered earnings and revenue surprises of 4.76% and 0.19%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023
04:05pm, Friday, 10'th Mar 2023
SAN DIEGO , March 10, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class tre
Akebia Therapeutics (AKBA) Reports Q4 Loss, Tops Revenue Estimates
01:45pm, Thursday, 09'th Mar 2023 Zacks Investment Research
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 71.43% and 14.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
06:10pm, Wednesday, 22'nd Feb 2023 Benzinga
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formula
Best Penny Stocks This Week? 4 Short Squeeze Stocks To Watch
05:35pm, Wednesday, 22'nd Feb 2023 PennyStocks
Short interest is high on these penny stocks. Time to buy or avoid them entirely?
The post Best Penny Stocks This Week? 4 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Picks, Ne
Best Penny Stocks This Week? 4 Short Squeeze Stocks To Watch
12:35pm, Wednesday, 22'nd Feb 2023
Short interest is high on these penny stocks. Time to buy or avoid them entirely?
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
05:58pm, Monday, 06'th Feb 2023 Benzinga
Gainers
Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600.
Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.
SoundHound AI, Inc. (NASDAQ: SOUN) shares climbed 39.7% to $3.9394. Shar
10 Top Penny Stocks To Watch With High Short Interest This Week
02:39pm, Tuesday, 20'th Dec 2022
Short squeeze penny stocks to buy now or avoid entirely? The post 10 Top Penny Stocks To Watch With High Short Interest This Week appeared first on Penny Stocks to Buy, Picks, News and Information | P
Penny Stocks To Buy Now? 6 Short Squeeze Stocks To Watch
04:08pm, Friday, 16'th Dec 2022 PennyStocks
Penny stocks to watch with higher short interest right now.
The post Penny Stocks To Buy Now? 6 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
Penny Stocks To Buy Now? 6 Short Squeeze Stocks To Watch
11:08am, Friday, 16'th Dec 2022
Penny stocks to watch with higher short interest right now. The post Penny Stocks To Buy Now?
7 Penny Stocks to Buy for 10-Bagger Returns
10:14pm, Tuesday, 15'th Nov 2022
Some good news is finally starting to creep into the markets with inflation easing in October. However, GDP growth remains a concern.
Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3
06:15pm, Wednesday, 09'th Nov 2022 Benzinga
Heron Therapeutics Inc (NASDAQ: HRTX) reported a Q3 EPS loss of $(0.38), in line with consensus, with sales of $26.60 million missing the consensus of $26.96 million.
Needham notes it was another u
